Tuesday, June 23, 2026

Prime Minister Kim Urges Global Asian Business Leaders to Help Tackle Middle East-Driven Economic Risks

Prime Minister Kim Min-seok warns of economic risks from Middle East tensions and urges World-OKTA to support crisis response efforts.

Will the U.S.’s Bitcoin Strategic Reserve Policy Boost Prices? White House Teases Major Announcement

Anticipation grows for the U.S. Bitcoin Strategic Reserve Policy, with potential legislation on the horizon to boost the virtual asset market.

North Korea Still Off-Limits for U.S. Travelers Until 2025

The U.S. has renewed its travel ban to North Korea for another year due to risks of arbitrary arrest and detention of Americans.

Tag: GC Biopharma

GC Biopharma Unveils mRNA Vaccine Strategy at Seoul Pandemic X Summit 2026: What’s Next for COVID-19?

GC Biopharma presents its mRNA vaccine strategy at the Seoul Pandemic X Summit 2026, focusing on rapid responses to future pandemics.

GC Biopharma Presents Aggregation Study of Alyglo IVIG… A New Benchmark for Safe Immunotherapy

GC Biopharma USA will present findings on IVIG formulations, highlighting Alyglo's lower protein aggregation and improved stability at NHIA 2026.

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

GC Biopharma’s Varicella Vaccine “VARICELLAJU” Wins Approval in Guatemala

GC Biopharma's varicella vaccine VARICELLAJU gains marketing approval in Guatemala, marking its Latin American debut and ensuring safety.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Top News

- Our Sponsors Ad -

Follow us